Search results for "Highlights"
ADA standards call for further tailoring of diabetes care to each patient
Doctors should further individualize care in the treatment of diabetes, the American Diabetes Association (ADA) stated in its 2014 Standards of Medical Care.
https://diabetes.acponline.org/archives/2014/01/10/1.htm
10 Jan 2014
No ‘obesity paradox’ for mortality found in diabetics
A new study found no evidence of a mortality benefit for diabetics in being obese or overweight and thus did not support the so-called “obesity paradox.”
https://diabetes.acponline.org/archives/2014/02/14/2.htm
14 Feb 2014
Spousal diabetes associated with personal increase in diabetes risk
Having a spouse with diabetes was associated with a 26% increase in personal diabetes risk, according to a recent study.
https://diabetes.acponline.org/archives/2014/02/14/3.htm
14 Feb 2014
Herbal capsule may lower risk of developing type 2 diabetes in prediabetes patients
Patients with impaired glucose tolerance who were treated with Chinese herbs for a year were significantly less likely to develop diabetes than matched patients who didn't take the herbs, a study found.
https://diabetes.acponline.org/archives/2014/02/14/1.htm
14 Feb 2014
Sulfonylurea as second-line therapy appeared to lower cost in a population-based model
Sulfonylurea as second-line therapy for glycemic control in type 2 diabetes appeared to yield similar outcomes and quality-adjusted life-years but led to lower costs and longer time to insulin dependence compared with a dipeptidyl peptidase-4 inhibitor, glucagon-like peptide-1 receptor agonist, and insulin, according to a recent study.
https://diabetes.acponline.org/archives/2014/03/14/2.htm
14 Mar 2014
Elderly patients most likely to land in ED, get admitted for insulin-related hypoglycemia
Elderly patients are more likely than younger patients to land in the ED and be hospitalized for insulin-related hypoglycemia and errors, a new study found.
https://diabetes.acponline.org/archives/2014/03/14/3.htm
14 Mar 2014
FDA finds no link between incretin-based drugs, pancreatic complications
Data do not support a causal association between incretin-based drugs and pancreatitis or pancreatic cancer, concluded a review by U.S. and European regulatory agencies.
https://diabetes.acponline.org/archives/2014/03/14/1.htm
14 Mar 2014
Novel algorithms could help individualize HbA1c goals
Two novel algorithms to individualize glycemic control targets would allow clinicians to set HbA1c goals, reclassify from one-quarter to one-third of patients as controlled instead of uncontrolled, and possibly improve treatment of certain patient populations, a study found.
https://diabetes.acponline.org/archives/2014/05/09/3.htm
9 May 2014
Studies suggest no elevated risk of pancreatitis with incretin-based drugs
A study and a meta-analysis suggest incretin-based drugs don't increase the risk of pancreatitis in patients with type 2 diabetes.
https://diabetes.acponline.org/archives/2014/05/09/2.htm
9 May 2014
ACE inhibitors improved all-cause mortality, cardiovascular outcomes versus ARBs
Angiotensin-converting enzyme (ACE) inhibitors improved all-cause mortality, cardiovascular mortality, and major cardiovascular events compared with angiotensin II receptor blockers (ARBs) in patients with diabetes, a new study found.
https://diabetes.acponline.org/archives/2014/05/09/1.htm
9 May 2014